ABAT and hepatocellular carcinoma: Besides, PCK1 and ABAT were significantly improved in HepG2 samples prepared with metformin and phenformin in GSE69850, suggesting that glycemic control in T2DM might be beneficial for improving survival outcomes in HCC by increasing the expressions of protective factors (Fig. 4e).